BACKGROUND: Prosthetic joint infection (PJI) is an important failure mechanism of total joint arthroplasty (TJA). Here we examine whether the particular genetic variants can lead to increased susceptibility to PJI development. RESULTS: We conducted a genetic-association study to determine whether PJI could be associated with functional cytokine gene polymorphisms (CGP) influencing on innate immunity response. A case-control design was utilized and previously published criteria for PJI were included to distinguish between cases and control subjects with/without TJA. Six single nucleotide polymorphisms (SNPs) located in the genes for interleukin-1beta (SNP: IL1B-511, +3962), tumour necrosis factor alpha (TNF-308, -238) and interleukin-6 (IL6-174, nt565) were genotyped in 303 Caucasian (Czech) patients with TJA (89 with PJI / 214 without PJI), and 168 unrelated healthy Czech individuals without TJA. The results showed that carriers of the less common IL1B-511*T allele were overrepresented in the group of TJA patients with PJI (69%) in comparison with those that did not develop PJI (51%, p = 0.006, p(corr) = 0.037) and with healthy controls (55%, p = 0.04, p(corr) = N.S.). There was no significant difference in the distribution of the remaining five investigated CGPs and their haplotypes between groups. CONCLUSION: A functional variant of the gene encoding for IL-1beta was preliminarily nominated as a genetic factor contributing to the susceptibility to PJI. Our results should be independently replicated; studies on the functional relevance of IL1B gene variants in PJI are also needed.

Laboratory of Immunogenomics and Immunoproteomics Faculty of Medicine and Dentistry Palacky University Olomouc IP Pavlova 6 Olomouc 77520 Czech Republic

Zobrazit více v PubMed

Cataldo MA, Petrosillo N, Cipriani M, Cauda R, Tacconelli E. Prosthetic joint infection: recent developments in diagnosis and management. J Infect. 2010;61:443–448. doi: 10.1016/j.jinf.2010.09.033. PubMed DOI

Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res. 2010;468:52–56. doi: 10.1007/s11999-009-1013-5. PubMed DOI PMC

Zimmerli W, Sendi P. Pathogenesis of implant-associated infection: the role of the host. Semin Immunopathol. 2011;33:295–306. doi: 10.1007/s00281-011-0275-7. PubMed DOI

Jamsen E, Furnes O, Engesaeter LB, Konttinen YT, Odgaard A, Stefansdottir A, Lidgren L. Prevention of deep infection in joint replacement surgery. Acta Orthop. 2010;81:660–666. doi: 10.3109/17453674.2010.537805. PubMed DOI PMC

Malik MH, Jury F, Bayat A, Ollier WE, Kay PR. Genetic susceptibility to total hip arthroplasty failure: a preliminary study on the influence of matrix metalloproteinase 1, interleukin 6 polymorphisms and vitamin D receptor. Ann Rheum Dis. 2007;66:1116–1120. doi: 10.1136/ard.2006.062018. PubMed DOI PMC

Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature. 2007;449:819–826. doi: 10.1038/nature06246. PubMed DOI

Lamkanfi M, Dixit VM. Inflammasomes: guardians of cytosolic sanctity. Immunol Rev. 2009;227:95–105. doi: 10.1111/j.1600-065X.2008.00730.x. PubMed DOI

Osawa R, Williams KL, Singh N. The inflammasome regulatory pathway and infections: role in pathophysiology and clinical implications. J Infect. 2011;62:119–129. doi: 10.1016/j.jinf.2010.10.002. PubMed DOI

Del Buono A, Denaro V, Maffulli N. Genetic susceptibility to aseptic loosening following total hip arthroplasty: a systematic review. Br Med Bull. 2012;101:39–55. doi: 10.1093/bmb/ldr011. PubMed DOI

Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol. 1995;99:303–310. PubMed PMC

Knight JC, Kwiatkowski D. Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proc Assoc Am Physicians. 1999;111:290–298. doi: 10.1046/j.1525-1381.1999.99237.x. PubMed DOI

Gallo J, Kolar M, Dendis M, Loveckova Y, Sauer P, Zapletalova J, Koukalova D. Culture and PCR analysis of joint fluid in the diagnosis of prosthetic joint infection. New Microbiol. 2008;31:97–104. PubMed

Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215. doi: 10.1093/nar/16.3.1215. PubMed DOI PMC

Kubistova Z, Mrazek F, Tudos Z, Kriegova E, Ambruzova Z, Mytilineos J, Petrek M. Distribution of 22 cytokine gene polymorphisms in the healthy Czech population. Int J Immunogenet. 2006;33:261–267. doi: 10.1111/j.1744-313X.2006.00609.x. PubMed DOI

Gallo J, Mrazek F, Petrek M. Variation in cytokine genes can contribute to severity of acetabular osteolysis and risk for revision in patients with ABG 1 total hip arthroplasty: a genetic association study. BMC Med Genet. 2009;10:109. doi: 10.1186/1471-2350-10-109. PubMed DOI PMC

Hansen JA. Immunobiology of the human MHC. Proceedings of the 13th International Histocompatibility Workshop and Conference. Volume I. Seattle: IHWG Press; 2007.

Chatterjee N, Chen YH, Luo S, Carroll RJ. Analysis of Case–control Association Studies: SNPs, Imputation and Haplotypes. Stat Sci. 2009;24:489–502. doi: 10.1214/09-STS297. PubMed DOI PMC

Lalouel JM, Rohrwasser A. Power and replication in case–control studies. Am J Hypertens. 2002;15:201–205. doi: 10.1016/S0895-7061(01)02285-3. PubMed DOI

Excoffier L, Laval G, Schneider S. Arlequin version 3.0: an integrated software package for population genetics data analysis. Evol Bioinformatics Online. 2005;1:47–50. PubMed PMC

Plenge RM, Bridges SL Jr, Huizinga TW, Criswell LA, Gregersen PK. Recommendations for publication of genetic association studies in Arthritis & Rheumatism. Arthritis Rheum. 2011;63:2839–2847. doi: 10.1002/art.30509. PubMed DOI

Malik MH, Bayat A, Jury F, Kay PR, Ollier WE. Genetic susceptibility to total hip arthroplasty failure–positive association with mannose-binding lectin. J Arthroplasty. 2007;22:265–270. doi: 10.1016/j.arth.2006.02.163. PubMed DOI

Malik MH, Bayat A, Jury F, Ollier WE, Kay PR. Genetic susceptibility to hip arthroplasty failure–association with the RANK/OPG pathway. Int Orthop. 2006;30:177–181. doi: 10.1007/s00264-006-0074-2. PubMed DOI PMC

Malik M. Genetic susceptibility to hip arthroplasty failure-association with the RANK/OPG pathway. Erratum. Int Orthop. 2009;33:297. doi: 10.1007/s00264-007-0473-z. PubMed DOI PMC

van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA. Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol. 2011;32:110–116. doi: 10.1016/j.it.2011.01.003. PubMed DOI

Lamkanfi M. Emerging inflammasome effector mechanisms. Nat Rev Immunol. 2011;11:213–220. doi: 10.1038/nri2936. PubMed DOI

Jotanovic Z, Etokebe GE, Mihelic R, Heiland Karvatn M, Mulac-Jericevic B, Tijanic T, Balen S, Sestan B, Dembic Z. Hip osteoarthritis susceptibility is associated with IL1B −511(G>A) and IL1 RN (VNTR) genotypic polymorphisms in Croatian Caucasian population. J Orthop Res. 2011;29:1137–1144. doi: 10.1002/jor.21378. PubMed DOI

Lea WI, Lee YH. The associations between interleukin-1 polymorphisms and susceptibility to ankylosing spondylitis: A meta-analysis. Joint Bone Spine. 2012;79:370–374. doi: 10.1016/j.jbspin.2011.06.010. PubMed DOI

Hall SK, Perregaux DG, Gabel CA, Woodworth T, Durham LK, Huizinga TW, Breedveld FC, Seymour AB. Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum. 2004;50:1976–1983. doi: 10.1002/art.20310. PubMed DOI

Wen AQ, Gu W, Wang J, Feng K, Qin L, Ying C, Zhu PF, Wang ZG, Jiang JX. Clinical relevance of IL-1beta promoter polymorphisms (−1470, -511, and −31) in patients with major trauma. Shock. 2010;33:576–582. PubMed

Notarangelo LD. Primary immunodeficiencies. J Allergy Clin Immunol. 2010;125:S182–S194. doi: 10.1016/j.jaci.2009.07.053. PubMed DOI

El-Helou O, Berbari EF, Brown RA, Gralewski JH, Osmon DR, Razonable RR. Functional assessment of Toll-like receptor 2 and its relevance in patients with Staphylococcus aureus infection of joint prosthesis. Hum Immunol. 2011;72:47–53. doi: 10.1016/j.humimm.2010.10.001. PubMed DOI

Pedersen AB, Mehnert F, Johnsen SP, Sorensen HT. Risk of revision of a total hip replacement in patients with diabetes mellitus: a population-based follow up study. J Bone Joint Surg Br. 2010;92:929–934. doi: 10.1302/0301-620X.92B7.24461. PubMed DOI

Peel TN, Dowsey MM, Daffy JR, Stanley PA, Choong PF, Buising KL. Risk factors for prosthetic hip and knee infections according to arthroplasty site. J Hosp Infect. 2011;79:129–133. doi: 10.1016/j.jhin.2011.06.001. PubMed DOI

Aslam S, Reitman C, Darouiche RO. Risk factors for subsequent diagnosis of prosthetic joint infection. Infect Control Hosp Epidemiol. 2010;31:298–301. doi: 10.1086/650756. PubMed DOI

Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty. 2009;24:105–109. doi: 10.1016/j.arth.2009.04.027. PubMed DOI

Dorshkind K, Montecino-Rodriguez E, Signer RA. The ageing immune system: is it ever too old to become young again? Nat Rev Immunol. 2009;9:57–62. doi: 10.1038/nri2471. PubMed DOI

Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br. 2005;87:844–850. doi: 10.1302/0301-620X.87B6.15121. PubMed DOI

Pedersen AB, Svendsson JE, Johnsen SP, Riis A, Overgaard S. Risk factors for revision due to infection after primary total hip arthroplasty. A population-based study of 80,756 primary procedures in the Danish Hip Arthroplasty Registry. Acta Orthop. 2010;81:542–547. doi: 10.3109/17453674.2010.519908. PubMed DOI PMC

Muilwijk J, Walenkamp GH, Voss A, Wille JC, van den Hof S. Random effect modelling of patient-related risk factors in orthopaedic procedures: results from the Dutch nosocomial infection surveillance network 'PREZIES'. J Hosp Infect. 2006;62:319–326. doi: 10.1016/j.jhin.2005.08.006. PubMed DOI

Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen WS, Osmon DR. Risk factors for prosthetic joint infection: case–control study. Clin Infect Dis. 1998;27:1247–1254. doi: 10.1086/514991. PubMed DOI

Willis-Owen CA, Konyves A, Martin DK. Factors affecting the incidence of infection in hip and knee replacement: an analysis of 5277 cases. J Bone Joint Surg Br. 2010;92:1128–1133. doi: 10.1302/0301-620X.92B8.24333. PubMed DOI

Mahomed NN, Barrett JA, Katz JN, Phillips CB, Losina E, Lew RA, Guadagnoli E, Harris WH, Poss R, Baron JA. Rates and outcomes of primary and revision total hip replacement in the United States medicare population. J Bone Joint Surg Am. 2003;85-A:27–32. PubMed

Mraovic B, Suh D, Jacovides C, Parvizi J. Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty. J Diabetes Sci Technol. 2011;5:412–418. PubMed PMC

Urquhart DM, Hanna FS, Brennan SL, Wluka AE, Leder K, Cameron PA, Graves SE, Cicuttini FM. Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a systematic review. J Arthroplasty. 2010;25:1216–1222. doi: 10.1016/j.arth.2009.08.011. e1-3. PubMed DOI

Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J. et al.STrengthening the REporting of Genetic Association Studies (STREGA)–an extension of the STROBE statement. Genet Epidemiol. 2009;33:581–598. doi: 10.1002/gepi.20410. PubMed DOI

Janssens AC, Ioannidis JP, Duijn CM, Little J, Khoury MJ. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. BMJ. 2011;342:d631. doi: 10.1136/bmj.d631. PubMed DOI PMC

Antibacterial surface treatment for orthopaedic implants

Coding variants of TLR2 and TLR4 genes do not substantially contribute to prosthetic joint infection